ABVC - ABVC BioPharma Inc. Net earnings per share (EPS TTM)

Symbol and logo of brand ABVC BioPharma, Inc. (ABVC)

The clinical success of plant-based remedies and payments from Asian partners are driving the utilization of ABVC BioPharma production lines. Fundamental TTM net income per share clearly confirms this correlation, where the value -0.29 serves as the baseline indicator of current efficiency. Completing the picture is a reputation as an ethical innovator merging Eastern medicine with Western quality standards.

ABVC (ABVC BioPharma) Net earnings per one share for the last twelve months history from 07/04/2022 to 11/09/2026

Summary analytical data breakdowns for ABVC BioPharma Inc. (ABVC)

- share price and expert price forecast:
Stock Quotes ABVC BioPharma|ABVC - Analyst Forecast Prices
- market capitalization statistics:
Market Capitalization ABVC BioPharma, Inc.|ABVC - Value Adjusted for Debt and Cash
- business book valuation details:
Book Value per Share ABVC BioPharma|ABVC - Total Stockholders' Equity|Market Value to Book Value Ratio abvcpharma.com|ABVC - Aggregate Asset Value
- debt obligations and liquidity statistics:
Total Debt to Capital ABVC BioPharma|ABVC - Long-Term Debt to Capital|Short-Term Debt to Capital ABVC BioPharma Inc|ABVC - Company Debts|Debt to Book Value ABVC BioPharma, Inc.|ABVC - Company Long-Term Debt|Company Short-Term Debts ABVC BioPharma|Quick Liquidity Indicator abvcpharma.com
- net income and valuation multiples indicators:
ABVC - Final Profit|Projected Future Earnings ABVC BioPharma|ABVC - Price to Earnings Ratio|Forward P/E Multiple ABVC BioPharma, Inc.|ABVC - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ABVC BioPharma, Inc.|ABVC - Profit before interest, taxes and amortization|Earnings per share for the last twelve months ABVC BioPharma|ABVC - Earnings per one share for the last 12 months|Quarterly EPS earnings growth abvcpharma.com|ABVC - Earnings per share increase in current year|Earnings growth forecast for next year ABVC BioPharma
Fundamental company valuation:ABVC BioPharma - ABVC
Manufactured products of ABVC BioPharma Inc.

ABVC BioPharma monetizes innovative biologics through licenses and clinical trial milestone payments. By analyzing the current rolling trailing twelve-month net income per share, an investor assesses the real income per unit of capital. This metric strips the financial result of the impact of issuance volume, revealing the true efficiency of the business. It allows for the filtering of random fluctuations and highlights the impact of operating expenses on margins. Steady growth in this indicator confirms the fundamental value of the assets.

Competitor analysis for ABVC BioPharma

HLN: Net earnings per share for the last 12 months|kenvue.com - Earnings per share for the last four quarters|VRNA: Net earnings per share (EPS TTM)|Jyong Biotech Limited - Earnings per share for the trailing year|LGND (Ligand Pharma) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Amneal Corp AMRX|Earnings per share for the last twelve months Perrigo Company plc (PRGO)|ALVO (alvotech.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) LQDA (Liquidia)|Net earnings per share (EPS TTM) Galapagos N.V. GLPG|ANI Pharma - Net earnings per share (EPS TTM)|MNKD: Earnings per share for the last twelve months|AMPH (Amphastar Pharmaceuticals) - Net earnings per share for the last 12 months|PCRX (pacira.com) - Earnings per share for the last twelve months|SPRY (ARS Pharmaceuticals, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Theravance Biopharma Inc (TBPH)|Net earnings per share for the last 12 months AQST (Aquestive Pharma)|SCPH (scpharmaceuticals.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) TECX (Tectonic Therapeutic)|tonixpharma.com - Earnings per share for the last twelve months|SXT China - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Eupraxia Pharmaceuticals EPRX|BioHarvest (BHST) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Invizyne (EXOZ)|Earnings per share for the last twelve months Oramed|Entera Bio Corp - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) HYFT|CPIX (Cumberland Pharmaceuticals Inc) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) QNTM (Quantum BioPharma Limited)|Net earnings per share (EPS TTM) FibroGen Corporation FGEN|TELO - Earnings per share for the last twelve months|Earnings per share for the trailing year RANI (Rani Therapeutics)|synergychc.com (SNYR) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Rallybio|LEXX (Lexaria Bioscience Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Pulmatrix Corporation|Net earnings per share (EPS TTM) PTHL|Net earnings per share (EPS TTM) aptorumgroup.com (APM)|Net earnings per share (EPS TTM) LYRA (Lyra Therapeutics)|Impact BioMedical, Inc. - Earnings per share for the last twelve months|TNFA: Net earnings per share for the last 12 months|YCBD: Earnings per share for the last twelve months|PRFX: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Altamira Therapeutics Ltd.|Earnings per share for the last twelve months Lipella Pharmaceuticals, Inc.|OptiNose Inc - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) PIRS|PROC (Procaps Group Corp) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) PTPI (Petros Pharmaceuticals)|Net earnings per share (EPS TTM) qlsyy.net QLI|SLRN - Earnings per share for the last twelve months|Earnings per share for the trailing year TFFP (TFF Pharmaceuticals Inc.)